Start for free
Start for free
Yael Capital Management Limited logo

Yael Capital Management Limited

Asia, Guangdong, China, Shenzhen

Description

Yael Capital focuses on private equity investment and fund management.

Investor Profile

Yael Capital Management Limited has made 7 investments, with 4 in the past 12 months and 14% as lead.

Stage Focus

  • Seed (43%)
  • Series A (29%)
  • Angel (14%)
  • Series Unknown (14%)

Country Focus

  • China (57%)
  • United States (43%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Biopharma
  • Life Science
  • Artificial Intelligence (Ai)
  • Health Care
  • Alternative Medicine
  • Genetics
  • Therapeutics
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Yael Capital Management Limited frequently co-invest with?

K2VC
K2VC
Asia, Beijing, China, Beijing
Co-Investments: 1
BeiGene
BeiGene
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
UpHonest Capital
UpHonest Capital
North America, California, United States, Palo Alto
Co-Investments: 1
XC
Xiaochi Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
LG
Life Garden Venture capital
Asia, Beijing, China, Beijing
Co-Investments: 1
5Y Capital
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 3
XtalPi
XtalPi
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
IMO Ventures
IMO Ventures
North America, California, United States, San Mateo
Co-Investments: 4
Taihill Venture
Taihill Venture
North America, Massachusetts, United States, Boston
Co-Investments: 2
Tiantu Capital
Tiantu Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 3

What are some of recent deals done by Yael Capital Management Limited?

META Pharmaceuticals

Shenzhen, Guangdong, China

META Pharmaceuticals is a cutting-edge drug development company specializing in autoimmune diseases.

MedicalPharmaceutical
Series UnknownFeb 17, 2025
Merda Biopharma

Futian, Guangdong, China

Merda Biopharma is a AI-enabled drug discovery technology platform that produces small molecule drugs that helps immune metabolism.

BiopharmaBiotechnology
Series AFeb 14, 2025
ReviR Therapeutics

Brisbane, California, United States

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Alternative MedicineBiotechnologyGeneticsTherapeutics
Series AJul 26, 2024
Amount Raised: $30,000,000
Recorna Bio

Guangzhou, Guangdong, China

Recorna Bio is a biotechnology company that provides research and development for RNA editing and genome modifications.

BiopharmaBiotechnologyLife Science
SeedJun 28, 2024
Insight Technology

Guangzhou, Guangdong, China

Insight Technology is an instrument manufacturer and seller company.

ManufacturingSales
SeedMar 22, 2024
Regenerative Bio

Cambridge, Massachusetts, United States

Regenerative Bio is the world's first anti-aging biotechnology company driven by artificial intelligence and cloud supercomputing.

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceutical
AngelFeb 25, 2022
Amount Raised: $10,000,000
Signet Therapeutics

Newton, Massachusetts, United States

Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.

BiotechnologyLife Science
SeedOct 29, 2021
Amount Raised: $10,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator